Contineum Therapeutics
@contineum-tx.com
We are pioneering new therapies for conditions at the intersection of NI&I.
Contineum Therapeutics's Company Logos
Contineum Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#434692
Victoria
67, 70, 146
238, 37, 42
54, 52, 0, 43
#7A3FF1
Electric Violet
122, 63, 241
260, 86, 60
49, 74, 0, 5
#180D43
Violet
24, 13, 67
252, 68, 16
64, 81, 0, 74
About Contineum Therapeutics
Continuem Therapeutics is a pioneering brand dedicated to improving the Neurology, Immunology, and Inflammation (NI&I) space through the development of precision small molecules. Their innovative approach focuses on creating therapeutic solutions that aim to transform the trajectory of clinical impairment. By combining cutting-edge science with a commitment to patient well-being, Continuem Therapeutics endeavors to redefine the standards of care in healthcare.
With a team of expert scientists, staff, and board members at the helm, the brand offers programs like PIPE-791 and PIPE-307, aimed at addressing specific healthcare needs. Continuem Therapeutics also values transparency with patients, investors, and the wider community, as evidenced by their comprehensive publications and regular engagement through news and events. Explore the future of healthcare with Continuem Therapeutics at their San Diego headquarters, where life is reconnected through groundbreaking research and development efforts
Company type
Privately Held
Year founded
2017
Company size
11-50 employees
Related Brands
Tags
Small-molecule drugs
Neurology, inflammation and immunology (NI&I) therapeutics
Idiopathic pulmonary fibrosis (IPF) treatments
Multiple sclerosis (MS) therapies
Inflammation and fibrosis targeting
